Literature DB >> 7747211

Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems.

A Gafni1, S Birch.   

Abstract

In this paper we critically appraise the appropriateness and validity from an economic perspective of alternative preference-based approaches to measuring outcomes in economic evaluations of health care interventions. We describe the properties of an outcome measure for economic evaluation to make it compatible with the principles of economics when applied to the problem of resource allocation. We also describe the difference and similarities between the psychometric and the economic approaches for the measurement of outcome. Using these properties we critically appraise the use of QALY and HYE methods of measuring individual and social preferences for health outcome. We argue that the most advanced measure currently available that meets these required properties is the HYE. Because the HYE, unlike the QALY, has its foundations in utility theory under uncertainty, it neither assumes particular formulations of the individual utility function, nor is it incompatible with the principles of economics. As such it represents a further stage in the continuing development of methods for economic evaluation of health care programmes.

Mesh:

Year:  1995        PMID: 7747211     DOI: 10.1016/0277-9536(94)e0109-6

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  8 in total

Review 1.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

Review 2.  Valuing health-related quality of life. Issues and controversies.

Authors:  P Dolan
Journal:  Pharmacoeconomics       Date:  1999-02       Impact factor: 4.981

3.  Willingness to pay. What's in a name?

Authors:  A Gafni
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

4.  Alternatives to the QALY measure for economic evaluations.

Authors:  A Gafni
Journal:  Support Care Cancer       Date:  1997-03       Impact factor: 3.603

5.  Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression.

Authors:  Maria Orlando Edelen; M Audrey Burnam; Katherine E Watkins; José J Escarce; Haiden Huskamp; Howard H Goldman; Gary Rachelefsky
Journal:  Med Decis Making       Date:  2008-08-25       Impact factor: 2.583

Review 6.  Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach.

Authors:  Yuan Zhang; Pablo Alonso Coello; Jan Brożek; Wojtek Wiercioch; Itziar Etxeandia-Ikobaltzeta; Elie A Akl; Joerg J Meerpohl; Waleed Alhazzani; Alonso Carrasco-Labra; Rebecca L Morgan; Reem A Mustafa; John J Riva; Ainsley Moore; Juan José Yepes-Nuñez; Carlos Cuello-Garcia; Zulfa AlRayees; Veena Manja; Maicon Falavigna; Ignacio Neumann; Romina Brignardello-Petersen; Nancy Santesso; Bram Rochwerg; Andrea Darzi; Maria Ximena Rojas; Yaser Adi; Claudia Bollig; Reem Waziry; Holger J Schünemann
Journal:  Health Qual Life Outcomes       Date:  2017-05-02       Impact factor: 3.186

7.  Determining Value in Health Technology Assessment: Stay the Course or Tack Away?

Authors:  J Jaime Caro; John E Brazier; Jonathan Karnon; Peter Kolominsky-Rabas; Alistair J McGuire; Erik Nord; Michael Schlander
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

8.  Improving Cross-Sector Comparisons: Going Beyond the Health-Related QALY.

Authors:  John Brazier; Aki Tsuchiya
Journal:  Appl Health Econ Health Policy       Date:  2015-12       Impact factor: 2.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.